Insider: MURPHY ANDREW J EVP Research - REGENERON PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 54,294 | 0 | 54,294 |
| Value | $41,363,883.90 | $0.00 | $41,363,883.90 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/14/2024 | DDS | 148 | Direct | COM | $1,145.58 | $169,545.84 | 54,294 |
| 08/14/2024 | DDS | 537 | Direct | COM | $1,148.52 | $616,755.24 | 53,706 |
| 08/14/2024 | DDS | 294 | Direct | COM | $1,149.60 | $337,982.40 | 53,412 |
| 08/14/2024 | DDS | 45 | Direct | COM | $1,144.89 | $51,520.05 | 54,442 |
| 08/14/2024 | DDS | 79 | Direct | COM | $1,143.28 | $90,319.12 | 54,487 |
| 08/14/2024 | DDS | 331 | Direct | COM | $1,159.69 | $383,857.39 | 48,306 |
| 08/14/2024 | DDS | 55 | Direct | COM | $1,140.31 | $62,717.05 | 54,614 |
| 08/14/2024 | DDS | 48 | Direct | COM | $1,142.94 | $54,861.12 | 54,566 |
| 08/14/2024 | DDS | 844 | Direct | COM | $1,150.41 | $970,946.04 | 52,568 |
| 08/14/2024 | DDS | 51 | Direct | COM | $1,146.60 | $58,476.60 | 54,243 |
| 08/14/2024 | DDS | 1,016 | Direct | COM | $1,156.43 | $1,174,932.88 | 49,004 |
| 08/14/2024 | DDS | 185 | Direct | COM | $1,151.46 | $213,020.10 | 52,383 |
| 08/14/2024 | DDS | 189 | Direct | COM | $1,158.78 | $219,009.42 | 48,637 |
| 08/14/2024 | DDS | 402 | Direct | COM | $1,155.76 | $464,615.52 | 50,020 |
| 08/14/2024 | DDS | 178 | Direct | COM | $1,157.41 | $206,018.98 | 48,826 |
| 08/14/2024 | DDS | 197 | Direct | COM | $1,152.36 | $227,014.92 | 52,186 |
| 08/14/2024 | DDS | 987 | Direct | COM | $1,153.74 | $1,138,741.38 | 51,199 |
| 08/14/2024 | DDS | 777 | Direct | COM | $1,154.66 | $897,170.82 | 50,422 |
| 03/14/2024 | DDS | 545 | Direct | COM | $955.54 | $520,769.30 | 51,472 |
| 03/14/2024 | DDS | 1,108 | Direct | COM | $956.34 | $1,059,624.72 | 50,364 |
| 03/14/2024 | DDS | 870 | Direct | COM | $954.66 | $830,554.20 | 52,017 |
| 03/14/2024 | DDS | 182 | Direct | COM | $951.92 | $173,249.44 | 53,907 |
| 03/14/2024 | DDS | 730 | Direct | COM | $957.35 | $698,865.50 | 49,634 |
| 03/14/2024 | DDS | 444 | Direct | COM | $952.40 | $422,865.60 | 53,463 |
| 03/14/2024 | DDS | 576 | Direct | COM | $953.77 | $549,371.52 | 52,887 |
| 1 2 3 4 5 6 7 8 Next Last You are at page 1 of 8 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research